{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:27:44Z","timestamp":1793071664609,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["3 Biotech"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s13205-022-03304-1","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T04:02:32Z","timestamp":1660968152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Exploring actinomycetes natural products to identify potential multi-target inhibitors against Leishmania donovani"],"prefix":"10.1007","volume":"12","author":[{"given":"Satyendra","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-0596","authenticated-orcid":false,"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"issue":"6, Part 1","key":"3304_CR1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.biotechadv.2015.06.003","volume":"33","author":"UR Abdelmohsen","year":"2015","unstructured":"Abdelmohsen UR, Grkovic T, Balasubramanian S, Kamel MS, Quinn RJ, Hentschel U (2015) Elicitation of secondary metabolism in actinomycetes. Biotechnol Adv 33(6, Part 1):798\u2013811. https:\/\/doi.org\/10.1016\/j.biotechadv.2015.06.003","journal-title":"Biotechnol Adv"},{"key":"3304_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/978-1-4613-0455-5_25","volume-title":"Purines and myocardial protection","author":"KC Agarwal","year":"1996","unstructured":"Agarwal KC (1996) Purines and regulation of platelet activation. Purines and myocardial protection. Springer, Boston, MA, US, pp 409\u2013418"},{"key":"3304_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fimmu.2017.00107","volume":"8","author":"PK Ahluwalia","year":"2017","unstructured":"Ahluwalia PK, Pandey RK, Sehajpal PK, Prajapati VK (2017) Perturbed microRNA expression by mycobacterium tuberculosis promotes macrophage polarization leading to pro-survival foam cell. Front Immunol 8:107. https:\/\/doi.org\/10.3389\/fimmu.2017.00107","journal-title":"Front Immunol"},{"key":"3304_CR4","unstructured":"Balasubramaniam DM, Williams DP (2020) WebGRO for Macromolecular Simulations."},{"issue":"1","key":"3304_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1107\/S174430911004724X","volume":"67","author":"KL Barrack","year":"2011","unstructured":"Barrack KL, Tulloch LB, Burke L-A, Fyfe PK, Hunter WN, Communications C (2011) Structure of recombinant Leishmania donovani pteridine reductase reveals a disordered active site. Acta Crystallogr Sect f: Struct Biol Cryst Commun 67(1):33\u201337","journal-title":"Acta Crystallogr Sect f: Struct Biol Cryst Commun"},{"key":"3304_CR6","first-page":"252","volume-title":"4th International conference on computational physics (PC 92)","author":"H Bekker","year":"1993","unstructured":"Bekker H, Berendsen H, Dijkstra E, Achterop S, Vondrumen R, Vanderspoel D, Sijbers A, Keegstra H, Renardus M (1993) Gromacs-a parallel computer for molecular-dynamics simulations. 4th International conference on computational physics (PC 92). World Scientific Publishing, Singapore, pp 252\u2013256"},{"issue":"1","key":"3304_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ja.2005.1","volume":"58","author":"J B\u00e9rdy","year":"2005","unstructured":"B\u00e9rdy J (2005) Bioactive microbial metabolites. J Antibiot 58(1):1\u201326. https:\/\/doi.org\/10.1038\/ja.2005.1","journal-title":"J Antibiot"},{"issue":"4","key":"3304_CR8","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jmb.2009.12.032","volume":"396","author":"JA Brannigan","year":"2010","unstructured":"Brannigan JA, Smith BA, Yu Z, Brzozowski AM, Hodgkinson MR, Maroof A, Price HP, Meier F, Leatherbarrow RJ, Tate EW, Smith DF, Wilkinson AJ (2010) N-Myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis. J Mol Biol 396(4):985\u2013999. https:\/\/doi.org\/10.1016\/j.jmb.2009.12.032","journal-title":"J Mol Biol"},{"issue":"1","key":"3304_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11302-014-9436-1","volume":"11","author":"G Burnstock","year":"2015","unstructured":"Burnstock G, Pelleg A (2015) Cardiac purinergic signalling in health and disease. Purinergic Signalling 11(1):1\u201346","journal-title":"Purinergic Signalling"},{"issue":"2","key":"3304_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1021\/jm960814j","volume":"41","author":"C Chan","year":"1998","unstructured":"Chan C, Yin H, Garforth J, McKie JH, Jaouhari R, Speers P, Douglas KT, Rock PJ, Yardley V, Croft SL (1998) Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. J Med Chem 41(2):148\u2013156","journal-title":"J Med Chem"},{"key":"3304_CR11","doi-asserted-by":"publisher","DOI":"10.2174\/1386207320666170615104703","author":"S Chander","year":"2017","unstructured":"Chander S, Pandey RK, Penta A, Choudhary BS, Sharma M, Malik R, Prajapati VK, Murugesan S (2017) Molecular docking and molecular dynamics simulation based approach to explore the dual inhibitor against HIV-1 reverse transcriptase and integrase. Comb Chem High Throughput Screen. https:\/\/doi.org\/10.2174\/1386207320666170615104703","journal-title":"Comb Chem High Throughput Screen"},{"issue":"1","key":"3304_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1021\/acsinfecdis.8b00226","volume":"5","author":"V Corpas-Lopez","year":"2018","unstructured":"Corpas-Lopez V, Moniz S, Thomas M, Wall RJ, Torrie LS, Zander-Dinse D, Tinti M, Brand S, Stojanovski L, Manthri S (2018) Pharmacological validation of N-myristoyltransferase as a drug target in Leishmania donovani. ACS Infect Dis 5(1):111\u2013122","journal-title":"ACS Infect Dis"},{"key":"3304_CR13","unstructured":"Diseases (2017) Global leishmaniasis update, 2006\u20132015: a turning point in leishmaniasis surveillance"},{"issue":"26","key":"3304_CR14","first-page":"265","volume":"96","author":"N Gill","year":"2021","unstructured":"Gill N, Pandey D, Roy N, Dhingra N, Jain S (2021) Kala-azar in India \u2013 progress and challenges towards its elimination as a public health problem. Wkly Epidemiol Rec 96(26):265\u2013280","journal-title":"Wkly Epidemiol Rec"},{"key":"3304_CR15","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.2147\/DDDT.S133127","volume":"11","author":"Y Glantz-Gashai","year":"2017","unstructured":"Glantz-Gashai Y, Meirson T, Reuveni E, Samson AO (2017) Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance. Drug Des Dev Ther 11:1803","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"3304_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0378-1097(88)90240-6","volume":"54","author":"HF Hassan","year":"1988","unstructured":"Hassan HF, Coombs GH (1988) Purine and pyrimidine metabolism in parasitic protozoa. FEMS Microbiol Lett 54(1):47\u201383. https:\/\/doi.org\/10.1016\/0378-1097(88)90240-6","journal-title":"FEMS Microbiol Lett"},{"issue":"31","key":"3304_CR17","doi-asserted-by":"publisher","first-page":"19488","DOI":"10.1074\/jbc.272.31.19488","volume":"272","author":"HY Hwang","year":"1997","unstructured":"Hwang HY, Ullman B (1997) Genetic analysis of purine metabolism in Leishmania donovani. J Biol Chem 272(31):19488\u201319496","journal-title":"J Biol Chem"},{"issue":"2","key":"3304_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.molbiopara.2008.12.007","volume":"164","author":"A Jhingran","year":"2009","unstructured":"Jhingran A, Chawla B, Saxena S, Barrett MP, Madhubala R (2009) Paromomycin: uptake and resistance in Leishmania donovani. Mol Biochem Parasitol 164(2):111\u2013117. https:\/\/doi.org\/10.1016\/j.molbiopara.2008.12.007","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"3304_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0304-3940(98)00227-4","volume":"246","author":"AI Jim\u00e9nez","year":"1998","unstructured":"Jim\u00e9nez AI, Castro E, Delicado EG, Miras-Portugal MT (1998) Potentiation of adenosine 5\u2032-triphosphate calcium responses by diadenosine pentaphosphate in individual rat cerebellar astrocytes. Neurosci Lett 246(2):109\u2013111","journal-title":"Neurosci Lett"},{"issue":"2065","key":"3304_CR20","doi-asserted-by":"publisher","first-page":"20150202","DOI":"10.1098\/rsta.2015.0202","volume":"374","author":"IT Jolliffe","year":"2016","unstructured":"Jolliffe IT, Cadima J (2016) Principal component analysis: a review and recent developments. Phil Trans R Soc a: Math, Phy, Eng Sci 374(2065):20150202","journal-title":"Phil Trans R Soc a: Math, Phy, Eng Sci"},{"key":"3304_CR21","unstructured":"Kaur J, Dube D, Ramachandran R, Singh P, Singh N (2012) Thianthrene is a novel inhibitor of Leishmania donovani pteridine reductase 1 (PTR1). J Mol Biochem 1 (2)"},{"issue":"1","key":"3304_CR22","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1038\/s41598-017-09725-w","volume":"7","author":"P Kaur","year":"2017","unstructured":"Kaur P, Garg M, Hombach-Barrigah A, Clos J (2017) MAPK1 of Leishmania donovani interacts and phosphorylates HSP70 and HSP90 subunits of foldosome complex. Sci Rep 7(1):10202. https:\/\/doi.org\/10.1038\/s41598-017-09725-w","journal-title":"Sci Rep"},{"issue":"1","key":"3304_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2915.1990.tb00255.x","volume":"4","author":"R Killick-Kendrick","year":"1990","unstructured":"Killick-Kendrick R (1990) Phlebotomine vectors of the leishmaniases: a review. Med Vet Entomol 4(1):1\u201324","journal-title":"Med Vet Entomol"},{"issue":"7","key":"3304_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00284-018-1452-x","volume":"75","author":"Y Kimura","year":"2018","unstructured":"Kimura Y, Tanaka C, Oka M (2018) Identification of major enzymes involved in the synthesis of diadenosine tetraphosphate and\/or adenosine tetraphosphate in Myxococcus xanthus. Curr Microbiol 75(7):811\u2013817","journal-title":"Curr Microbiol"},{"issue":"1","key":"3304_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.exppara.2008.05.005","volume":"120","author":"P Kumar","year":"2008","unstructured":"Kumar P, Kumar A, Verma SS, Dwivedi N, Singh N, Siddiqi MI, Tripathi RP, Dube A, Singh N (2008) Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies. Exp Parasitol 120(1):73\u201379. https:\/\/doi.org\/10.1016\/j.exppara.2008.05.005","journal-title":"Exp Parasitol"},{"issue":"7","key":"3304_CR26","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari R, Kumar R, Lynn A (2014) g_mmpbsa\u2014a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54(7):1951\u20131962. https:\/\/doi.org\/10.1021\/ci500020m","journal-title":"J Chem Inf Model"},{"issue":"11","key":"3304_CR27","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s00210-021-02133-y","volume":"394","author":"L Li","year":"2021","unstructured":"Li L, Yang M, Li C, Liu Y (2021) Virtual screening based identification of miltefosine and octenidine as inhibitors of heat shock protein 90. Naunyn Schmiedebergs Arch Pharmacol 394(11):2223\u20132232. https:\/\/doi.org\/10.1007\/s00210-021-02133-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"3304_CR28","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0021-9258(19)44380-9","volume":"248","author":"GE Lienhard","year":"1973","unstructured":"Lienhard GE, Secemski II (1973) P1, P5-Di (adenosine-5\u2032) pentaphosphate, a potent multisubstrate inhibitor of adenylate kinase. J Biol Chem 248(3):1121\u20131123","journal-title":"J Biol Chem"},{"issue":"1","key":"3304_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0166-6851(83)90053-1","volume":"9","author":"DL Looker","year":"1983","unstructured":"Looker DL, Berens RL, Marr JJ (1983) Purine metabolism in Leishmania donovani amastigotes and promastigotes. Mol Biochem Parasitol 9(1):15\u201328","journal-title":"Mol Biochem Parasitol"},{"issue":"D1","key":"3304_CR30","doi-asserted-by":"publisher","first-page":"D1130","DOI":"10.1093\/nar\/gks1253%JNucleicAcidsResearch","volume":"41","author":"X Lucas","year":"2012","unstructured":"Lucas X, Senger C, Erxleben A, Gr\u00fcning BA, D\u00f6ring K, Mosch J, Flemming S, G\u00fcnther S (2012) StreptomeDB: a resource for natural compounds isolated from Streptomyces species. Nucleic Acids Res 41(D1):D1130\u2013D1136. https:\/\/doi.org\/10.1093\/nar\/gks1253%JNucleicAcidsResearch","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3304_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27(3):221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"3304_CR32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/infdis\/136.6.724","volume":"136","author":"JJ Marr","year":"1977","unstructured":"Marr JJ, Berens RL (1977) Antileishmanial effect of allopurinol. II. Relationship of adenine metabolism in Leishmania species to the action of allopurinol. J Infect Dis 136(6):724\u2013732","journal-title":"J Infect Dis"},{"issue":"D1","key":"3304_CR33","doi-asserted-by":"publisher","first-page":"D600","DOI":"10.1093\/nar\/gkaa868","volume":"49","author":"AF Moumbock","year":"2021","unstructured":"Moumbock AF, Gao M, Qaseem A, Li J, Kirchner PA, Ndingkokhar B, Bekono BD, Simoben CV, Babiaka SB, Malange YI (2021) StreptomeDB 3.0: an updated compendium of streptomycetes natural products. Nucleic Acids Res 49(D1):D600\u2013D604","journal-title":"Nucleic Acids Res"},{"key":"3304_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1931451","author":"B Naik","year":"2021","unstructured":"Naik B, Mattaparthi VSK, Gupta N, Ojha R, Das P, Singh S, Prajapati VK, Prusty DJJoBS, Dynamics, (2021) Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1931451","journal-title":"J Biomol Struct Dyn"},{"issue":"10","key":"3304_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/glycob\/cwg099","volume":"13","author":"K-i Nakayama","year":"2003","unstructured":"Nakayama K-i, Maeda Y, Jigami Y (2003) Interaction of GDP-4-keto-6-deoxymannose-3, 5-epimerase-4-reductase with GDP-mannose-4, 6-dehydratase stabilizes the enzyme activity for formation of GDP-fucose from GDP-mannose. Glycobiology 13(10):673\u2013680","journal-title":"Glycobiology"},{"issue":"21","key":"3304_CR36","doi-asserted-by":"publisher","first-page":"13883","DOI":"10.1074\/jbc.272.21.13883","volume":"272","author":"B Nare","year":"1997","unstructured":"Nare B, Hardy LW, Beverley SM (1997) The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major. J Biol Chem 272(21):13883\u201313891","journal-title":"J Biol Chem"},{"issue":"13","key":"3304_CR37","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/jcc.20090","volume":"25","author":"C Oostenbrink","year":"2004","unstructured":"Oostenbrink C, Villa A, Mark AE, Van Gunsteren WF (2004) A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem 25(13):1656\u20131676","journal-title":"J Comput Chem"},{"key":"3304_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.09.110","author":"RK Pandey","year":"2017","unstructured":"Pandey RK, Prajapati VK (2017) Molecular and immunological toxic effects of nanoparticles. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.09.110","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"3304_CR39","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1080\/07391102.2015.1085904","volume":"33","author":"RK Pandey","year":"2015","unstructured":"Pandey RK, Sharma D, Bhatt TK, Sundar S, Prajapati VK (2015) Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach. J Biomol Struct Dyn 33(12):2541\u20132553. https:\/\/doi.org\/10.1080\/07391102.2015.1085904","journal-title":"J Biomol Struct Dyn"},{"key":"3304_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biopha.2016.06.010","volume":"83","author":"RK Pandey","year":"2016","unstructured":"Pandey RK, Verma P, Sharma D, Bhatt TK, Sundar S, Prajapati VK (2016) High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania. Biomed Pharmacother 83:141\u2013152. https:\/\/doi.org\/10.1016\/j.biopha.2016.06.010","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3304_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/07391102.2015.1135298","volume":"35","author":"RK Pandey","year":"2017","unstructured":"Pandey RK, Kumbhar BV, Srivastava S, Malik R, Sundar S, Kunwar A, Prajapati VK (2017a) Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation. J Biomol Struct Dyn 35(1):141\u2013158. https:\/\/doi.org\/10.1080\/07391102.2015.1135298","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"3304_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/10799893.2016.1171344","volume":"37","author":"RK Pandey","year":"2017","unstructured":"Pandey RK, Kumbhar BV, Sundar S, Kunwar A, Prajapati VK (2017b) Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase. J Recept Signal Transduct Res 37(1):60\u201370. https:\/\/doi.org\/10.3109\/10799893.2016.1171344","journal-title":"J Recept Signal Transduct Res"},{"issue":"4","key":"3304_CR43","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/07391102.2016.1161560","volume":"35","author":"RK Pandey","year":"2017","unstructured":"Pandey RK, Narula A, Naskar M, Srivastava S, Verma P, Malik R, Shah P, Prajapati VK (2017c) Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation. J Biomol Struct Dyn 35(4):791\u2013804. https:\/\/doi.org\/10.1080\/07391102.2016.1161560","journal-title":"J Biomol Struct Dyn"},{"issue":"13","key":"3304_CR44","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1093\/emboj\/18.13.3533","volume":"18","author":"CL Phillips","year":"1999","unstructured":"Phillips CL, Ullman B, Brennan RG, Hill CP (1999) Crystal structures of adenine phosphoribosyltransferase from Leishmania donovani. EMBO J 18(13):3533\u20133545. https:\/\/doi.org\/10.1093\/emboj\/18.13.3533","journal-title":"EMBO J"},{"key":"3304_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-981-10-5187-6_6","volume-title":"Drug design: principles and applications","author":"VK Prajapati","year":"2017","unstructured":"Prajapati VK, Pandey RK (2017) Recent advances in the chemotherapy of visceral leishmaniasis. Drug design: principles and applications. Springer, Singapore, pp 69\u201388"},{"issue":"4","key":"3304_CR46","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4269\/ajtmh.2012.12-0022","volume":"87","author":"VK Prajapati","year":"2012","unstructured":"Prajapati VK, Mehrotra S, Gautam S, Rai M, Sundar S (2012) In vitro antileishmanial drug susceptibility of clinical isolates from patients with Indian visceral leishmaniasis\u2013status of newly introduced drugs. Am J Trop Med Hyg 87(4):655\u2013657. https:\/\/doi.org\/10.4269\/ajtmh.2012.12-0022","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"3304_CR47","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.bbrc.2017.09.135","volume":"493","author":"GS Reddy","year":"2017","unstructured":"Reddy GS, Mukhopadhyay AG, Dey CS (2017) The p38 MAP kinase inhibitor, PD 169316, inhibits flagellar motility in Leishmania donovani. Biochem Biophys Res Commun 493(4):1425\u20131429","journal-title":"Biochem Biophys Res Commun"},{"issue":"35","key":"3304_CR48","first-page":"401","volume":"96","author":"JA Ruiz-Postigo","year":"2020","unstructured":"Ruiz-Postigo JA, Jain S, Mikhailov A, Maia-Elkhoury AN, Valadas S, Warusavithana S, Osman M, Lin Z, Beshah A, Yajima A, Gasimov E (2020) Global leishmaniasis surveillance: 2019\u20132020, a baseline for the 2030 roadmap. Wkly Epidemiol Rec 96(35):401\u2013420","journal-title":"Wkly Epidemiol Rec"},{"key":"3304_CR49","unstructured":"Schr\u00f6dinger Release 2017a-4 (2017a) LigPrep S, LLC, New York, NY."},{"key":"3304_CR50","unstructured":"Schr\u00f6dinger Release 2017b-4 (2017b) QikProp S, LLC, New York, NY"},{"key":"3304_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11030-022-10452-2","volume":"28","author":"S Singh","year":"2022","unstructured":"Singh S, Kumar K, Panda M, Srivastava A, Mishra A, Prajapati VK (2022) High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases. Mol Diversity 28:1\u201323. https:\/\/doi.org\/10.1007\/s11030-022-10452-2","journal-title":"Mol Diversity"},{"key":"3304_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fmicb.2016.00183","volume":"7","author":"M Soares-Silva","year":"2016","unstructured":"Soares-Silva M, Diniz FF, Gomes GN, Bahia D (2016) The mitogen-activated protein kinase (MAPK) pathway: role in immune evasion by trypanosomatids. Front Microbiol 7:183. https:\/\/doi.org\/10.3389\/fmicb.2016.00183","journal-title":"Front Microbiol"},{"issue":"9","key":"3304_CR53","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/383321%JClinicalInfectiousDiseases","volume":"38","author":"J Soto","year":"2004","unstructured":"Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Diaz A, Luz M, Gutierrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H (2004) Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis 38(9):1266\u20131272. https:\/\/doi.org\/10.1086\/383321%JClinicalInfectiousDiseases","journal-title":"Clin Infect Dis"},{"issue":"14","key":"3304_CR54","doi-asserted-by":"publisher","first-page":"8193","DOI":"10.1074\/jbc.273.14.8193","volume":"273","author":"FX Sullivan","year":"1998","unstructured":"Sullivan FX, Kumar R, Kriz R, Stahl M, Xu G-Y, Rouse J, Chang X-j, Boodhoo A, Potvin B, Cumming DA (1998) Molecular cloning of human GDP-mannose 4, 6-dehydratase and reconstitution of GDP-fucose biosynthesis in vitro. J Biol Chem 273(14):8193\u20138202","journal-title":"J Biol Chem"},{"issue":"3","key":"3304_CR55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1086\/380971","volume":"38","author":"S Sundar","year":"2004","unstructured":"Sundar S, Mehta H, Suresh AV, Singh SP, Madhukar R, Murray HW (2004) Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clin Infect Dis 38(3):377\u2013383. https:\/\/doi.org\/10.1086\/380971","journal-title":"Clin Infect Dis"},{"issue":"25","key":"3304_CR56","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1056\/NEJMoa066536","volume":"356","author":"S Sundar","year":"2007","unstructured":"Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK (2007) Injectable paromomycin for visceral leishmaniasis in India. N Engl J Med 356(25):2571\u20132581. https:\/\/doi.org\/10.1056\/NEJMoa066536","journal-title":"N Engl J Med"},{"issue":"4","key":"3304_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/cid\/cis474","volume":"55","author":"S Sundar","year":"2012","unstructured":"Sundar S, Singh A, Rai M, Prajapati VK, Singh AK, Ostyn B, Boelaert M, Dujardin J-C, Chakravarty J (2012) Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis 55(4):543\u2013550. https:\/\/doi.org\/10.1093\/cid\/cis474","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3304_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/s0031182013000450","volume":"141","author":"EW Tate","year":"2014","unstructured":"Tate EW, Bell AS, Rackham MD, Wright MH (2014) N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis. Parasitology 141(1):37\u201349. https:\/\/doi.org\/10.1017\/s0031182013000450","journal-title":"Parasitology"},{"issue":"2","key":"3304_CR59","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1046\/j.1365-2958.1998.00968.x","volume":"29","author":"J Tovar","year":"1998","unstructured":"Tovar J, Wilkinson S, Mottram JC, Fairlamb AH (1998) Evidence that trypanothione reductase is an essential enzyme in leishmania by targeted replacement of the tryA gene locus. Mol Microbiol 29(2):653\u2013660","journal-title":"Mol Microbiol"},{"issue":"3","key":"3304_CR60","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/mmbr.00005-07","volume":"71","author":"M Ventura","year":"2007","unstructured":"Ventura M, Canchaya C, Tauch A, Chandra G, Fitzgerald GF, Chater KF, van Sinderen D (2007) Genomics of actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol Mol Biol Rev 71(3):495\u2013548. https:\/\/doi.org\/10.1128\/mmbr.00005-07","journal-title":"Microbiol Mol Biol Rev"},{"key":"3304_CR61","doi-asserted-by":"crossref","unstructured":"Wernimont AK, Loppnau P, Walker JR, Mangos M, El Bakkouri M, Arrowsmith CH, Edwards AM, Bountra C, Hui R, Amani M (2014) Crystal structure of MapK from Leishmania donovani, LDBPK_331470. Structural Genomics Consortium (SGC)","DOI":"10.2210\/pdb4qny\/pdb"}],"container-title":["3 Biotech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-022-03304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13205-022-03304-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-022-03304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T20:38:26Z","timestamp":1661805506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13205-022-03304-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["3304"],"URL":"https:\/\/doi.org\/10.1007\/s13205-022-03304-1","relation":{},"ISSN":["2190-572X","2190-5738"],"issn-type":[{"value":"2190-572X","type":"print"},{"value":"2190-5738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,20]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"235"}}